GC Biopharma receives $10 million worth of ‘GCFLU’ order from Thailand

Reporter Paul Lee / approved : 2023-11-24 00:20:46
  • -
  • +
  • 인쇄

 

[Alpha Biz=(Chicago) Reporter Paul Lee] GC Biopharma said on the 23rd that its flu vaccine "GCFLU" has won an order worth about $10 million in a 2024 bid for Thailand's state-run pharmaceutical company GPO (Government Pharmaceutical Organization).

This is the largest amount GC Biopharma has signed since entering the Thai flu vaccine market in 2014. The company explained that the terms and conditions of the contract, such as the contract amount and period, could change in the future following an agreement with the other country.

Meanwhile, GC Biopharma is the largest supplier of seasonal flu vaccines for an international organization under the WHO, which supplies flu vaccines to 63 countries around the world. So far, the cumulative production of the flu vaccine has exceeded 300 million doses.

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Dongwon F&B Ordered to Revise Unfair Dealer Contract Terms2025.12.23
Coupang Files Lawsuit Challenging Industrial Accident Ruling in Death of Warehouse Worker2025.12.23
Cho Hyun-bum, Chairman of Hankook & Company, Sentence Reduced to Two Years on Embezzlement and Breach of Trust Charges2025.12.23
Korea’s Tax Authority Launches Special Tax Probe into Coupang2025.12.23
Hanwha Qcells Briefly Filed, Then Withdrew U.S. Tariff Refund Lawsuit Citing Law Firm Error2025.12.23
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사